Related Experiment Video
Updated: Jul 10, 2026

Procedure for Human Saphenous Veins Ex Vivo Perfusion and External Reinforcement
Published on: October 1, 2014
Efficacy and Durability of Percutaneous Deep Vein Arterialization: A Systematic Review
Samuel E So1, Yiu Che Chan1, Stephen W Cheng1
1Division of Vascular & Endovascular Surgery, Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong SAR, China.
Insights
Endovascular deep vein arterialization (DVA) shows promise for no-option critical limb ischemia (NO-CLI) patients, with high technical success but significant amputation rates. Further research is needed to establish routine use.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Regenerative Medicine
Background:
- Peripheral arterial disease (PAD) management remains challenging for patients ineligible for conventional surgery.
- Endovascular deep vein arterialization (DVA) presents a novel approach for limb salvage in such cases.
- This review synthesizes current evidence on DVA's efficacy and safety in no-option critical limb ischemia (NO-CLI).
Approach:
- A systematic review adhering to PRISMA guidelines was conducted.
- Searches included "percutaneous deep vein arterialization" and "percutaneous deep venous arterialization" across major databases.
- Studies with ≥5 patients, excluding open or hybrid DVA, were analyzed for primary and secondary outcomes.
Key Points:
- Ten studies with 233 NO-CLI patients were reviewed, with a median follow-up of 12 months.
- Technical success rate reached 97%, with a major amputation rate of 21.8%.
- Wound healing was observed in 69.5%, with complication, reintervention, and mortality rates at 13.8%, 37.4%, and 15.7%, respectively.
Conclusions:
- Endovascular DVA appears safe for NO-CLI patients.
- However, current studies are small and have limited follow-up (<1 year).
- Level 1 evidence is lacking to support routine DVA implementation for NO-CLI.
Background:
Endovascular deep vein arteriaization (DVA) is a novel technique aimed at salvaging peripheral arterial disease unamenable to conventional surgical intervention. This study aims to review contemporary literature on the efficacy, safety, and durability of DVA on patients with no-option critical limb ischemia (NO-CLI).
Methods:
The study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, using predefined search terms of "percutaneous deep vein arterialization" or "percutaneous deep venous arterialization" in PubMed, Web of Sciences, OvidSP, and Embase. Only studies with 5 or more patients were included, and studies involving open or hybrid DVA were excluded. The primary outcomes included technical success and primary amputation rates. Secondary outcomes included rates of wound healing, complication, reintervention, and all-cause mortality.
Results:
Ten studies encompassing a total of 233 patients were included. Patients were primarily those deemed to have NO-CLI. The median follow-up period was 12 months (range 1-63 months). The technical success rate was 97% (95% confidence interval [CI] 96.2%-97.9%) and the major amputation rate was 21.8% (95% 21.1%-22.4%). The wound healing rate was 69.5% (95% CI 67.9-71.0%), complication rate was 13.8% (95% CI 11.7%-15.9%), reintervention rate was 37.4% (95% CI 34.9%-39.9%), and all-cause mortality rate was 15.7% (95% CI 14.1%-17.2%).
Conclusions:
Our study showed that endovascular DVA is safe for patients with NO-CLI. Nonetheless, studies were small with follow-up period of less than 1 year. There is currently lack of level 1 evidence to recommend routine use in patients with NO-CLI.
More Related Videos
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Hemodialysis I: Introduction

